LifeTech Scientific Corporation reported no change in either authorised or issued share capital for the month ended 30 June 2026.

Authorised/Registered Capital • Authorised shares remained at 40.00 billion ordinary shares with a par value of USD 0.00000125, keeping total authorised capital at USD 50,000.

Issued Shares and Public Float • Issued ordinary shares stood unchanged at 4.63 billion. • No treasury shares were held or cancelled. • The company confirmed compliance with Hong Kong’s minimum 25 % public-float requirement.

Share-Option Activity • Two share-option schemes recorded a combined lapse of 390,000 options during the month. – Scheme 1: 120,000 options lapsed, reducing outstanding options to 25.29 million. – Scheme 2: 270,000 options lapsed, reducing outstanding options to 282.95 million. • No options were exercised; consequently, no new shares were issued and no cash proceeds were received.

Other Securities • The company reported no warrants, convertibles, or other share-linked instruments outstanding or transacted during the period.

Overall, LifeTech Scientific’s share structure and capital base remained unchanged in June 2026, with only a modest reduction in outstanding share options.